Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
At Evolved, CPAs and tax professionals deliver a full range of services, geared toward every stage of your personal and business growth.
Reveal Surgical's Sentry system is using advanced optical techniques such as Raman spectroscopy along with sophisticated machine learning algorithms to identify tissues with diffusely infiltrative cancer in vivo, while in surgery.
MIM Solutions is using artificial intelligence and machine learning to address the worldwide fertility disorder occurring in an increasing number of countries. The company is currently developing two solutons that utilize AI to help couples struggling with infertility to conceive.
Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).
A conversation with a world renowned cardiac surgeon and legendary innovator. Why does what we do matter? Where can (and should) we go as an industry?
Definition Health has developed an "end-to-end" approach that offers virtual management, pre-operative assessment, and post-operative recovery monitoring for patients undergoing elective surgeries.
BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva.
CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. Their technology has been applied to products for dental and ophthalmic surgery.
The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.
The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more.
They are developing a miniaturized neuromodulation device for therapeutic applications
Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine.
The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency.
Early Detection has developed a test to detect an altered sugar associated only with precanceous and cancerous tissue. The test can be delivered at the point-of-care and provides in-office results for patients and providers.
Adaptix is developing an innovative, miniaturized flat panel X-ray source and associated software to transform existing X-ray systems into Digital Tomosynthesis systems to expand patient access to low-dose 3D imaging.
CereVasc's eShunt System is consists of an endovascularly implantable CSF shunt and associated delivery componentry designed to avoid the need for invasive surgery, general anesthesia, extended hospitalization, and post-procedure pain management.
Neovasc's products include Reducer, for the treatment of refractory angina and Tiara for the transcatheter treatment of mitral regurgitation.
ElectroPhysiology Frontiers is developing a unique, "single-shot" catheter for the ablation of atrial fibrillation. The device is being designed to deliver pulsed-field ablation (PFA) and radiofrequency ablation (RFA) to provide patients with a durable solution and reduce the need for subsequent interventions.
AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF).
The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today.
The company's technology aims to make "untreatable" debilitating neurological conditions treatable via the use of precision bioelectronic devices that target specific cellular behaviors at the microscale.
CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP).
BURL Concepts' SONAS is a portable, battery-powered ultrasound system that enables non-invasive brain perfusion assessment at the point-of-care. SONAS is used in combination with microbubble contrast agents to evaluate unilateral and bi-lateral cerebral perfusion
AtaCor is developing an innovative temporary pacing system that avoids the risks associated with transvenous leads.
TympaHealth has developed an all-in-one hearing assessment platform for use at the point-of-care, including retail stores & assisted living facilities. The platform features a high-resolution otoscope for visualizing the ear drum, real-time screening audiogram, and micro-suction for ear wax removal.
The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs.
Visura manufacturers the world's first, FDA-cleared, disposable camera, the TEECAD System, that seamlessly connects to a transesophageal echocardiogram (TEE) echo probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.
ZygoFix develops and commercializes its zLOCK system, a proprietary technology that adds "bend-ability" to joints and provide natural stabilization. The technology is currently used to achieve spinal fusion and spinal stability without screws.
The company's HEALTH-Dx platform utilizes an ingestible pill to continuously monitor cardiac and respiratory vital signs for up to a week at a time.